NC
Nexthera Capital Portfolio holdings
AUM
$120M
1-Year Return
20.18%
This Quarter Return
-1.68%
1 Year Return
+20.18%
3 Year Return
+117.79%
5 Year Return
–
10 Year Return
–
AUM
$120M
AUM Growth
+$37.7M
(+46%)
Cap. Flow
+$39.9M
Cap. Flow
% of AUM
33.26%
Top 10 Holdings %
Top 10 Hldgs %
71.57%
Holding
35
New
11
Increased
11
Reduced
1
Closed
12
Top Buys
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$11.2M |
| 2 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$6.99M |
| 3 |
Ascendis Pharma
ASND
|
$6.94M |
| 4 |
Pacira BioSciences
PCRX
|
$6.48M |
| 5 |
Neurocrine Biosciences
NBIX
|
$5.77M |
Top Sells
| 1 |
Heron Therapeutics
HRTX
|
$9.5M |
| 2 |
Bausch Health
BHC
|
$5.08M |
| 3 |
STML
Stemline Therapeutics, Inc.
STML
|
$4.18M |
| 4 |
Novartis
NVS
|
$3.83M |
| 5 |
CBAY
Cymabay Therapeutics
CBAY
|
$2.79M |
Sector Composition
| 1 | Healthcare | 92.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCPH
26
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| – | – |
-42,865
| Closed | -$995K |
|
|
CBAY
27
DELISTED
Cymabay Therapeutics
CBAY
| – | – |
-210,257
| Closed | -$2.79M |
|
|
ACOR
28
DELISTED
Acorda Therapeutics, Inc.
ACOR
| – | – |
-1,290
| Closed | -$2.06M |
|
|
CHMA
29
DELISTED
Chiasma, Inc. Common Stock
CHMA
| – | – |
-203,948
| Closed | -$1.06M |
|
|
STML
30
DELISTED
Stemline Therapeutics, Inc.
STML
| – | – |
-325,526
| Closed | -$4.18M |
|
|
31
Bausch Health
BHC
$2.72B
| – | – |
-205,660
| Closed | -$5.08M |
|
32
BioMarin Pharmaceuticals
BMRN
$11.1B
| – | – |
-8,250
| Closed | -$733K |
|
33
Exelixis
EXEL
$10.2B
| – | – |
-90,356
| Closed | -$2.15M |
|
|
34
Heron Therapeutics
HRTX
$201M
| – | – |
-388,623
| Closed | -$9.5M |
|
35
Kiniksa Pharmaceuticals
KNSA
$2.65B
| – | – |
-67,692
| Closed | -$1.22M |
|